Published in J Neurosci on July 18, 2007
Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J Neurosci (2011) 2.33
Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med (2010) 2.25
Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Nat Rev Neurol (2010) 2.20
Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons. Acta Neuropathol Commun (2015) 1.45
Amyloid-beta immunisation for Alzheimer's disease. Lancet Neurol (2008) 1.38
Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease. Am J Pathol (2009) 1.27
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease. Mol Neurodegener (2014) 1.24
Intracellular accumulation of amyloid-Beta - a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front Aging Neurosci (2010) 1.20
Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol Appl Pharmacol (2009) 1.08
Amyloid-beta immunotherapy for Alzheimer's disease. CNS Neurol Disord Drug Targets (2010) 1.07
Protein phosphatases and Alzheimer's disease. Prog Mol Biol Transl Sci (2012) 1.03
Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease. J Mol Med (Berl) (2009) 0.99
Neurotrophins enhance CaMKII activity and rescue amyloid-β-induced deficits in hippocampal synaptic plasticity. J Alzheimers Dis (2010) 0.99
Large aggregates are the major soluble Aβ species in AD brain fractionated with density gradient ultracentrifugation. PLoS One (2012) 0.96
Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers. J Biol Chem (2010) 0.94
Long-Term Potentiation at CA3-CA1 Hippocampal Synapses with Special Emphasis on Aging, Disease, and Stress. Front Aging Neurosci (2011) 0.94
NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease. Curr Neuropharmacol (2012) 0.93
Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds. J Biol Chem (2008) 0.90
Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapy. Neurotherapeutics (2008) 0.90
The S100B/RAGE Axis in Alzheimer's Disease. Cardiovasc Psychiatry Neurol (2010) 0.86
Consequences of inhibiting amyloid precursor protein processing enzymes on synaptic function and plasticity. Neural Plast (2012) 0.86
Changes in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice. Neurobiol Aging (2011) 0.86
Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology. Curr Alzheimer Res (2013) 0.85
Pathological brain plasticity and cognition in the offspring of males subjected to postnatal traumatic stress. Mol Psychiatry (2014) 0.85
Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease. Autoimmun Rev (2008) 0.84
The context preexposure facilitation effect in mice: a dose-response analysis of pretraining scopolamine administration. Behav Brain Res (2011) 0.83
The involvement of Cdk5 activator p35 in social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit in the transgenic mice. Neuropsychopharmacology (2011) 0.80
Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity. Neural Plast (2016) 0.80
Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1-42-injected rats and APP/PS1 transgenic mice. Acta Pharmacol Sin (2014) 0.78
AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease. Mol Ther (2015) 0.77
Amyloid-β-Induced Dysregulation of AMPA Receptor Trafficking. Neural Plast (2016) 0.77
Profile of gantenerumab and its potential in the treatment of Alzheimer's disease. Drug Des Devel Ther (2013) 0.77
Moderate Treadmill Exercise Protects Synaptic Plasticity of the Dentate Gyrus and Related Signaling Cascade in a Rat Model of Alzheimer's Disease. Mol Neurobiol (2014) 0.76
Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Mol Neurodegener (2016) 0.76
Molecular and Functional Characterization of Bacopa monniera: A Retrospective Review. Evid Based Complement Alternat Med (2015) 0.76
Effect of amyloids on the vesicular machinery: implications for somatic neurotransmission. Philos Trans R Soc Lond B Biol Sci (2015) 0.76
Beneficial catalytic immunity to abeta peptide. Rejuvenation Res (2010) 0.75
Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer's Disease. J Neuroimmune Pharmacol (2016) 0.75
Computational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-β on synaptic plasticity. Front Pharmacol (2014) 0.75
Parishin C's prevention of Aβ 1-42-induced inhibition of long-term potentiation is related to NMDA receptors. Acta Pharm Sin B (2016) 0.75
Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron (2003) 4.39
Epigenetic transmission of the impact of early stress across generations. Biol Psychiatry (2010) 3.55
Protein phosphatase 1 is a molecular constraint on learning and memory. Nature (2002) 2.91
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44
Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology. Brain (2010) 2.33
Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med (2010) 2.25
The gamma 2 subunit of GABA(A) receptors is required for maintenance of receptors at mature synapses. Mol Cell Neurosci (2003) 2.18
KAP1-mediated epigenetic repression in the forebrain modulates behavioral vulnerability to stress. Neuron (2008) 2.17
Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory. Cell (2007) 2.12
Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. Nat Med (2002) 2.12
Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol (2003) 2.10
Laboratory animal welfare: cage enrichment and mouse behaviour. Nature (2004) 2.10
Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations. Mol Cell Proteomics (2006) 2.09
The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci (2004) 2.07
Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol Neurobiol (2008) 2.03
Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. Arch Neurol (2003) 1.98
A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry (2005) 1.92
Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex (2006) 1.87
Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proc Natl Acad Sci U S A (2007) 1.84
Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila. J Neurosci (2004) 1.74
Epigenetic codes in cognition and behaviour. Behav Brain Res (2008) 1.56
Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol Aging (2006) 1.55
Protein phosphatase 1 regulates the histone code for long-term memory. J Neurosci (2009) 1.44
Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain. J Proteome Res (2009) 1.43
Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry (2004) 1.40
Amyloid-beta immunisation for Alzheimer's disease. Lancet Neurol (2008) 1.38
Control of the establishment of aversive memory by calcineurin and Zif268. Nat Neurosci (2008) 1.36
The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42. J Mol Biol (2009) 1.35
ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase. J Biol Chem (2009) 1.33
Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur J Neurosci (2003) 1.32
The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J (2006) 1.29
NCS-1 in the dentate gyrus promotes exploration, synaptic plasticity, and rapid acquisition of spatial memory. Neuron (2009) 1.29
Neural mechanisms of stress resilience and vulnerability. Neuron (2012) 1.29
Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain (2006) 1.27
Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. J Cell Sci (2009) 1.26
Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice. Am J Pathol (2003) 1.24
Influence of early stress on social abilities and serotonergic functions across generations in mice. PLoS One (2011) 1.22
Nonconscious formation and reactivation of semantic associations by way of the medial temporal lobe. Neuropsychologia (2003) 1.22
beta-Amyloid induces paired helical filament-like tau filaments in tissue culture. J Biol Chem (2003) 1.19
Implicit associative learning engages the hippocampus and interacts with explicit associative learning. Neuron (2005) 1.18
A functional genetic variation of the 5-HT2a receptor affects human memory. Nat Neurosci (2003) 1.16
Identification of combinatorial patterns of post-translational modifications on individual histones in the mouse brain. PLoS One (2012) 1.15
Epigenetic inheritance in mammals: evidence for the impact of adverse environmental effects. Neurobiol Dis (2009) 1.14
A central role for the small GTPase Rac1 in hippocampal plasticity and spatial learning and memory. Mol Cell Neurosci (2009) 1.14
The prion gene is associated with human long-term memory. Hum Mol Genet (2005) 1.14
Epigenetic dysregulation in cognitive disorders. Eur J Neurosci (2009) 1.13
Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum Mol Genet (2003) 1.11
A crosstalk between β1 and β3 integrins controls glycine receptor and gephyrin trafficking at synapses. Nat Neurosci (2010) 1.11
Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease. Neurodegener Dis (2012) 1.10
The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity. FEBS Lett (2004) 1.10
Epigenetic inheritance of disease and disease risk. Neuropsychopharmacology (2012) 1.07
Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology. Brain (2007) 1.06
Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice. J Neurosci (2009) 1.05
Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2006) 1.05
Inducible and neuron-specific gene expression in the adult mouse brain with the rtTA2S-M2 system. Genesis (2005) 1.04
Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J Neurosci (2010) 1.04
ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging (2003) 1.04
Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Mol Cell Biol (2007) 1.03
Neural functions of calcineurin in synaptic plasticity and memory. Learn Mem (2012) 1.03
Early life epigenetic programming and transmission of stress-induced traits in mammals: how and when can environmental factors influence traits and their transgenerational inheritance? Bioessays (2014) 1.03
NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin. Neuropharmacology (2005) 1.02
Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol (2011) 1.02
Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice. Neurobiol Dis (2004) 1.02
Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease. PLoS One (2011) 1.02
Reversible blockade of experience-dependent plasticity by calcineurin in mouse visual cortex. Nat Neurosci (2005) 1.00
Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAβ mice. J Neurosci (2012) 1.00
Inheritable effect of unpredictable maternal separation on behavioral responses in mice. Front Behav Neurosci (2011) 1.00
The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease. Eur J Neurosci (2005) 0.99
Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo. J Neurosci Res (2006) 0.98
Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit. Neurobiol Dis (2006) 0.98
Dynamic histone marks in the hippocampus and cortex facilitate memory consolidation. Nat Commun (2012) 0.98
CST3 genotype associated with exudative age related macular degeneration. Br J Ophthalmol (2002) 0.97
Collybistin is required for both the formation and maintenance of GABAergic postsynapses in the hippocampus. Mol Cell Neurosci (2008) 0.96
Passive immunization against beta-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation. J Biol Chem (2002) 0.96
Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A. Eur J Neurosci (2002) 0.96
Effects of memory consolidation on human hippocampal activity during retrieval. Cortex (2005) 0.95
Interactome of the amyloid precursor protein APP in brain reveals a protein network involved in synaptic vesicle turnover and a close association with Synaptotagmin-1. J Proteome Res (2012) 0.94
Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease. J Mol Med (Berl) (2004) 0.93
One month of human memory consolidation enhances retrieval-related hippocampal activity. Hippocampus (2005) 0.93
Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease. Amyloid (2003) 0.93
Association study of cholesterol-related genes in Alzheimer's disease. Neurogenetics (2007) 0.92
Transgenerational epigenetic effects on brain functions. Biol Psychiatry (2012) 0.92
Active hippocampus during nonconscious memories. Conscious Cogn (2003) 0.92
Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis. J Cereb Blood Flow Metab (2011) 0.92
Epigenetic marking of sperm by post-translational modification of histones and protamines. Epigenetics Chromatin (2014) 0.92
Protein kinase D controls the integrity of Golgi apparatus and the maintenance of dendritic arborization in hippocampal neurons. Mol Biol Cell (2009) 0.92
Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories. Neurobiol Aging (2008) 0.92
Mitochondrial DNA toxicity in forebrain neurons causes apoptosis, neurodegeneration, and impaired behavior. Mol Cell Biol (2010) 0.92
Different phosphatase-dependent mechanisms mediate long-term depression and depotentiation of long-term potentiation in mouse hippocampal CA1 area. Eur J Neurosci (2003) 0.92
Partial inhibition of PP1 alters bidirectional synaptic plasticity in the hippocampus. Eur J Neurosci (2006) 0.91